When evaluating a patient with newly identified interstitial lung disease, using a questionnaire may help clinicians identify potentially relevant exposures for hypersensitivity pneumonitis.
All articles by Virginia A. Schad, PharmD, RPh
High flow nasal cannula oxygen significantly reduced intubation and subsequent invasive mechanical ventilation, but did not affect case fatality in patients with COVID-19 admitted to the ICU for acute respiratory failure.
ASTHMAXcel Adventures is a gamified, guideline-based, pediatric mobile application that improves asthma control, knowledge, and quality of life, and reduces emergency department visits.
Preliminary evidence suggests that the CFHealthHub criteria are valid and useful in diagnosing chronic Pseudomonas aeruginosa in adults with cystic fibrosis.
Childhood asthma is associated with an increased risk of respiratory disease-related hospital admissions and death but not all-cause mortality in adulthood.
Regardless of the type of trauma, type of chest ultrasonography operator, or type of CUS probe used, the overall sensitivity of CUS is superior to supine chest x-ray for diagnosing pneumothorax.
In patients with COPD who have dyspnea and/or exercise intolerance, triple therapy is not superior to maintenance long-acting bronchodilator therapy, except in patients with a history of ≥1 exacerbations in the past year.
In response to the COVID-19 pandemic, a phased approach for resuming suspended allergy/immunology clinical services is advised, according to consensus recommendations.
In patients with COPD, subclinical left ventricular systolic dysfunction is likely to be detected when measured by tissue Doppler imaging, even in patients without pulmonary hypertension.
Researchers confirmed the feasibility of conducting a randomized, triple-blinded, sham-controlled trial of ambulatory oxygen delivered via portable oxygen concentrator to evaluate its effects in patients with interstitial lung disease.
Asthma is not a risk factor for SARS-CoV-2, and SARS-CoV-2 pneumonia may not induce severe asthma exacerbations.
Among infants with severe bronchiolitis, those with rhinovirus at hospitalization followed by a new rhinovirus infection had the highest risk of recurrent wheezing.
Use of tocilizumab may result in lower mortality in patients hospitalized for COVID-19 with evidence of cytokine release syndrome.
Treatment with mavrilimumab is associated with improved clinical outcomes compared with standard care in non-mechanically ventilated patients with severe COVID-19 pneumonia and systemic hyperinflammation.
Thoracic organ transplantation remains a viable treatment option in patients with Eisenmenger Syndrome, although these patients are considered higher risk than other potential transplant recipients.
In patients with cystic fibrosis, prolonged exposure to heat can lead to chloride-deficient metabolic alkalosis as a result of a loss of electrolytes through sweat.
A new genomic classifier added to bronchoscopic lung cryobiopsy increased the diagnostic confidence of physicians for interstitial lung disease.
Nonatopic asthma is associated with adverse outcomes and exacerbation risk in COPD, while patients having atopy alone and atopic asthma had less risk.
In critically ill patients with acute kidney injury, more intensive renal replacement therapy may lead to a greater risk of failure to extubate from mechanical ventilation.
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
Global quarantine as a result of the COVID-19 pandemic has decreased fossil fuel use which may affect allergic and respiratory diseases.
Antibody responses are induced after infection with SARS-CoV-2; therefore, antibody tests are critical tools in the clinical management and control of SARS-CoV-2 infection and COVID-19.
Balloon pulmonary angioplasty can improve quality of life in patients with chronic thromboembolic pulmonary hypertension mainly by improving “usual activities.”
Social distancing of families with children who have asthma is the best method for preventing coronavirus diseases 2019.
Bayesian machine learning algorithms can improve discrimination of risk stratification in pulmonary arterial hypertension.
The healthcare burden of the COVID-19 pandemic extends beyond patients who test positive for severe acute respiratory syndrome coronavirus 2.
In patients with pulmonary arterial hypertension, renal function is important for determining mortality risk and improves stratification of risk.
In patients with COVID-19, higher sputum cell expression of ACE2 and TMPRSS2 was observed in certain patients while lower expression was found in patients who used inhaled corticosteroids.
Patients with precapillary pulmonary hypertension and pulmonary vascular resistance who do meet the definition of PAH may have functional limitations and may benefit from therapy.
In patients with COPD, treatment with single-inhaler fluticasone furoate/umeclidinium/vilanterol resulted in more health status improvements and greater lung function benefit compared with multiple-inhaler triple therapy.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses